AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Processa Pharmaceuticals, Inc. Director's Dealing 2025

Sep 18, 2025

35172_dirs_2025-09-18_bb7a8e22-d5f9-42c5-9a27-87609a4c9e25.zip

Director's Dealing

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-07-24

Reporting Person: Guy Wendy (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	26339	Direct
Common Stock	8335	Indirect